European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8%
Topline Europe’s medicines regulator said Wednesday it could greenlight Novavax’s Covid-19 vaccine “within weeks” if data provided is able to demonstrate the shot’s efficacy and safety, a major boon for the Maryland-based biotech, which has been plagued with manufacturing difficulties and until November had not managed to bring a vaccine to market in its 34-year …
European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8% Read More »